These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
-
Apr 30, 2018
Pfenex Inc. (NYSE American: PFNX) announced today that its first quarter 2018 financial results will be released on Thursday, May 10, 2018, after the market close. Pfenex management will host a...
-
Apr 18, 2018
Pfenex Inc. (NYSE AMERICAN: PFNX) and China NT Pharma Group Company Limited (NT Pharma) (HKG:1011) today announced an agreement under which Pfenex granted NT Pharma non-exclusive development and...
-
Mar 15, 2018
Pfenex Inc. (NYSE American: PFNX) is a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology® to improve protein therapies for...
-
Mar 13, 2018
Pfenex Inc. (NYSE AMERICAN: PFNX), announced today that the company will present at Oppenheimer's 28th Annual Healthcare Conference in New York City. President and Chief Executive Officer, Eef...
-
Mar 8, 2018
Pfenex Inc. (NYSE American: PFNX) announced today that its fourth quarter and full year 2017 financial results will be released on Thursday, March 15, 2018, after the market close. Pfenex...
Feb 27, 2018Pfenex Inc. (NYSE AMERICAN: PFNX), announced today that the company will present at Barclay's 2018 Global Healthcare Conference in Miami Beach, Florida. President and Chief Executive Officer, Eef...
- Jan 4, 2018
Pfenex Inc. (NYSE American: PFNX) today announced the appointment of Susan A. Knudson as Chief Financial Officer, effective February 1, 2018. "After a thorough search, we are pleased to welcome...
- Dec 19, 2017
Pfenex Inc. (NYSE AMERICAN: PFNX) today announced the amendment of the 2016 agreement under which Pfenex granted Jazz Pharmaceuticals worldwide rights to develop and commercialize multiple early...
Nov 9, 2017Pfenex Inc. (NYSE AMERICAN: PFNX), announced today that it will be presenting at the Jefferies 2017 London Healthcare Conference on Wednesday, November 15th at 12:40 pm GMT / 7:40 pm ET. The...
Nov 9, 2017Pfenex Inc. (NYSE American: PFNX) is a clinical-stage biotechnology company developing complex therapeutic proteins. Using the patented Pfenex Expression Technology® platform, the Company has...